HB-501 (Hysensbio)

N/A

Report date: 2025/06/11 11:25:10

NME

Base Information

Drug NameHB-501 (Hysensbio)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionFibroblast modulators

TargetsUpdating

Therapy Area/IndicationsHealthy Aging

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHysensBio Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHealthy Aging

Inactive IndicationsN/A

ATC CodeN/A